Targeted Talks

Feb 27 2025 69 ep. 19 mins 8
Targeted Talks Podcast artwork

Targeted Oncology brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.

  Health & Fitness  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain

Feb 27 2025 27 mins  
David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology and the many advancements shaping lymphoma treatment today.

S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

Feb 06 2025 8 mins  
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.

S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment

Jan 15 2025 35 mins  
In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting advancements of artificial intelligence in 2024, specifically focusing on its transformative impact on early cancer detection.

S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research

Nov 14 2024 16 mins  
In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

Oct 31 2024 27 mins  
In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.

S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology

Oct 17 2024 16 mins  
Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.

S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer

Sep 26 2024 13 mins  
In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the ph

S5 Ep16: Foran Goes Beyond the Basics of BPDCN

Sep 17 2024 22 mins  
In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.

S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates

Aug 30 2024 30 mins  
In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.

S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel

Aug 15 2024 16 mins  
In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.